Study Stopped
Low study enrollment
Loop Duodenal Switch: Outcomes at One Year
The Effect of Loop Duodenal Switch Surgery in Morbidly Obese Patients on Weight Los at One Year.
1 other identifier
interventional
1
1 country
1
Brief Summary
The biliopancreatic diversion and duodenal switch (BPD-DS) is an accepted and published type of bariatric surgery in the United States. The BPD-DS procedure produces the most weight loss of any bariatric surgery commonly performed but has the highest risk of malnutrition and gastrointestinal side effects. The loop duodenal switch (L-DS) is a bariatric surgery which has been modified from a biliopancreatic diversion and duodenal switch to maintain excellent weight loss while possibly reducing side effects. The surgical modifications in this procedure include reducing the number of intestinal reconnections from two to one and reducing the amount of small intestine which is bypassed. The L-DS operation is considered experimental by the American Society of Metabolic and Bariatric Surgery as long-term data in large numbers of patients is not available for weight loss or side effects. The purpose of this study is to examine weight loss and other outcomes in the L-DS operation up to 1 year after the procedure. Study participants will be seen in the clinic at 2 and 6 weeks, and 3, 6, 9, and 12 months per the bariatric surgery center protocol. As part of these normally scheduled visits, weight loss and health status will be recorded. Labs will be checked at 3, 6, and 12 months for nutritional status. A survey to reassess health-related quality of life and gastrointestinal symptoms will be performed at 3 months, 6 months and 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2017
CompletedFirst Posted
Study publicly available on registry
July 2, 2017
CompletedStudy Start
First participant enrolled
August 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
May 7, 2020
CompletedAugust 29, 2023
August 1, 2023
1.7 years
June 22, 2017
August 25, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Excess weight loss
Excess weight loss at 1 year will be measured by comparing BMI at 1 year to the presurgical BMI. Body mass index (BMI) is calculated using the patient's height and weight. Height will be measured using a stadiometer and weight will be measured using the clinic's bariatric scale
1 year
Secondary Outcomes (11)
anesthesia
at surgery
Blood loss
at surgery
Surgery conversion
at surgery
Concomitant procedures
at surgery
Hospital LOS
at surgery
- +6 more secondary outcomes
Study Arms (1)
Loop DS Patients
EXPERIMENTALPatients who receive a Loop DS procedure
Interventions
Eligibility Criteria
You may qualify if:
- The subject must be 19-70 years of age at the time of enrollment.
- The subject must be willing and able to participate in the study procedures and to understand and sign the informed consent.
- The subject is under consideration for surgery for obesity or metabolic disease and elects to undergo a primary loop duodenal switch procedure or as a conversion procedure for failed, sustained weight loss after a sleeve gastrectomy or laparoscopic adjustable gastric band performed more than 12 months prior to time of evaluation.
- The subject has a BMI of greater than or equal to 40 kg/m2 at time of surgical consultation.
You may not qualify if:
- Subjects under 19 years of age or older than 70 years of age
- Subject is not willing or able to participate in the study procedures and understand the informed consent.
- The subject wishes to under a different bariatric procedure other than the loop duodenal switch.
- The subject has a BMI of less than 40 kg/m2 at the time of surgical consultation.
- Any female subject who is pregnant, or is actively breast-feeding
- Any subject who is considered to be part of a vulnerable population (eg. prisoners or those with psychological concerns or those without sufficient mental capacity)
- The procedure is an emergency procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Nebraska Medical Center
Omaha, Nebraska, 68198-6245, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vishal Kothari, MD
University of Nebraska
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2017
First Posted
July 2, 2017
Study Start
August 9, 2018
Primary Completion
May 7, 2020
Study Completion
May 7, 2020
Last Updated
August 29, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share
We do not plan to share individual participant data with other researchers.